BBI Life Sciences Corporation recommended final dividend of HKD 0.034 per share for the year ended December 31, 2018 increased by approximately 142.9% compared with the year of 2017(2017: HKD 0.014). The Final Dividend is subject to the approval by the Shareholders at the upcoming annual general meeting of the Company to be held on 28 June 2019. The Final Dividend, if approved, is expected to be paid on 31 July 2019 to the Shareholders whose names appear on the register of members of the Company on 5 July 2019.